About us Pricing ContactSubscribe

reviewTop 1% cited

How were new medicines discovered?

Nature Reviews Drug Discovery · 2011 · Vol. 10(7) · pp. 507–519

David C. Swinney✉(Roche (United States))Jason Anthony(Roche (United States))

View via DOI Publisher page

Computational Drug Discovery Methods Biotechnology and Related Fields Bioinformatics and Genomic NetworksDrug discoveryFood and drug administrationDrugPhenotypic screeningMedicinePharmacologyComputational biologyMechanism (biology)Small moleculeDrug development

MeSH terms

Pharmacological PhenomenaDrug IndustryDrug Evaluation, PreclinicalHumansUnited StatesUnited States Food and Drug AdministrationDrug DesignDrug ApprovalDrug DiscoveryMolecular Targeted TherapyDrug-Related Side Effects and Adverse Reactions

Citations

1,768

FWCI

140.64

field-weighted impact

References

175

Percentile

100%

vs. same field & year

Citations per year

Cited by

A comprehensive map of molecular drug targets

Nature Reviews Drug Discovery · 2016 · 2,383 citations

Diagnosing the decline in pharmaceutical R&D efficiency

Nature Reviews Drug Discovery · 2012 · 1,911 citations

Systematic integration of biomedical knowledge prioritizes drugs for repurposing

eLife · 2017 · 579 citations

References

Enzyme Structure and Mechanism

FEBS Letters · 1978 · 760 citations

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

Nature Reviews Drug Discovery · 2004 · 2,577 citations

How many drug targets are there?

Nature Reviews Drug Discovery · 2006 · 3,473 citations

Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors

Journal of Pharmacology and Experimental Therapeutics · 2002 · 915 citations

Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Journal of Medicinal Chemistry · 2005 · 930 citations

Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity

Antimicrobial Agents and Chemotherapy · 2005 · 1,144 citations

Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety

CHEST Journal · 2001 · 1,571 citations

Cell Signaling by Receptor Tyrosine Kinases

Cell · 2010 · 7,809 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.